{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:27:06Z","timestamp":1790072826908,"version":"4.0.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>This study investigated whether a radiomic analysis of pretreatment <jats:sup>18<\/jats:sup>F-FDG PET can predict prognosis in patients with Hodgkin lymphoma (HL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Forty-two patients who were diagnosed as having HL and underwent pretreatment <jats:sup>18<\/jats:sup>F-FDG PET scans were retrospectively enrolled. For each patient, we extracted 450 radiomic features from PET images. The prognostic significance of the clinical and radiomic features was assessed in relation to progression-free survival (PFS) and overall survival (OS). Receiver operating characteristic curve, Cox proportional hazards regression, and Kaplan-Meier analyses were performed to examine the potential independent predictors and to evaluate the predictive value.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Intensity nonuniformity extracted from a gray-level run-length matrix and the Ann Arbor stage were independently associated with PFS (hazard ratio [HR] = 22.8, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; HR = 7.6, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.024) and OS (HR = 14.5, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.012; HR = 8.5, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048), respectively. In addition, SUV kurtosis was an independent prognosticator for PFS (HR = 6.6, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.026). We devised a prognostic scoring system based on these 3 risk predictors. The proposed scoring system further improved the risk stratification of the current staging classification (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The radiomic feature intensity nonuniformity is an independent prognostic predictor of PFS and OS in patients with HL. We devised a prognostic scoring system, which may be more beneficial for patient risk stratification in guiding therapy compared with the current Ann Arbor staging system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002732","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:13:13Z","timestamp":1563192793000},"page":"e559-e565","source":"Crossref","is-referenced-by-count":54,"title":["Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Kun-Han","family":"Lue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Feng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hsin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Cheng","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu-Chi University, Hualien"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keh-Shih","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hon","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hung","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Buddhist Tzu Chi General Hospital, Hualien"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.723","article-title":"Epidemiology of Hodgkin's disease: a review","volume":"22","year":"2004","journal-title":"Hematol Oncol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0145-2126(01)00126-6","article-title":"Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data","volume":"26","year":"2002","journal-title":"Leuk Res"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ajh.25071","article-title":"Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management","volume":"93","year":"2018","journal-title":"Am J Hematol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/cancers10050145","article-title":"[18F] FDG-PET\/CT in Hodgkin lymphoma: current usefulness and perspectives","volume":"10","year":"2018","journal-title":"Cancer"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2017-07-795476","article-title":"Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial","volume":"131","year":"2018","journal-title":"Blood"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2017-04-773838","article-title":"Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation","volume":"131","year":"2018","journal-title":"Blood"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2017-06-788877","article-title":"Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma","volume":"130","year":"2017","journal-title":"Blood"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","article-title":"Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/cas.12282","article-title":"Metabolic tumor volume by positron emission tomography\/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma","volume":"104","year":"2013","journal-title":"Cancer Sci"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","year":"2011","journal-title":"Cell"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2017.12.268","article-title":"Challenges and promises of PET radiomics","volume":"102","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib13-20230925","first-page":"563","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","year":"2015","journal-title":"Radiology"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/jrr\/rrx102","article-title":"Radiomics and radiogenomics for precision radiotherapy","volume":"59","year":"2018","journal-title":"J Radiat Res"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmp.2017.05.071","article-title":"Beyond imaging: the promise of radiomics","volume":"38","year":"2017","journal-title":"Phys Med"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1088\/0031-9155\/61\/13\/R150","article-title":"Applications and limitations of radiomics","volume":"61","year":"2016","journal-title":"Phys Med Biol"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41598-018-37197-z","article-title":"A PET radiomics model to predict refractory mediastinal Hodgkin lymphoma","volume":"9","year":"2019","journal-title":"Sci Rep"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1109\/34.295913","article-title":"Seeded region growing","volume":"16","year":"1994","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","article-title":"OsiriX: an open-source software for navigating in multidimensional DICOM images","volume":"17","year":"2004","journal-title":"J Digit Imaging"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/s41598-018-28243-x","article-title":"The role of PET-based radiomic features in predicting local control of esophageal cancer treated with concurrent chemoradiotherapy","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","year":"2014","journal-title":"Nat Commun"},{"key":"bib24-20230925","first-page":"248505","article-title":"Development and evaluation of an open-source software package \u201cCGITA\u201d for quantifying tumor heterogeneity with molecular images","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"bib26-20230925","first-page":"289","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","year":"1995","journal-title":"J R Stat Soc"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","year":"1950","journal-title":"Cancer"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygeno.2015.03.001","article-title":"Alterations in cancer cell metabolism: the Warburg effect and metabolic adaptation","volume":"105","year":"2015","journal-title":"Genomics"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/RLU.0000000000001578","article-title":"Value of intratumoral metabolic heterogeneity and quantitative 18F-FDG PET\/CT parameters to predict prognosis in patients with HPV-positive primary oropharyngeal squamous cell carcinoma","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41598-017-01524-7","article-title":"Metabolic radiomics for pretreatment 18F-FDG PET\/CT to characterize locally advanced breast cancer: histopathologic characteristics, response to neoadjuvant chemotherapy, and prognosis","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/RLU.0000000000001375","article-title":"Intratumoral heterogeneity of pretreatment 18F-FDG PET images predict disease progression in patients with nasal type extranodal natural killer\/T-cell lymphoma","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00259-014-2933-1","article-title":"Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0146-664X(75)80008-6","article-title":"Texture analysis using gray level run lengths","volume":"4","year":"1975","journal-title":"Comput Graph Image Proc"},{"key":"bib34-20230925","first-page":"E22","article-title":"Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography\/computed tomography combined with plasma Epstein-Barr virus load predicts prognosis in patients with primary nasopharyngeal carcinoma","volume":"127","year":"2017","journal-title":"Laryngoscope"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1148\/radiol.2015141309","article-title":"Non\u2013small cell lung cancer treated with erlotinib: heterogeneity of (18)F-FDG uptake at PET\u2014association with treatment response and prognosis","volume":"276","year":"2015","journal-title":"Radiology"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"key":"bib37-20230925","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2967\/jnumed.116.181347","article-title":"(18)F-FDG PET\/CT in lymphoma: has imaging-directed personalized medicine become a reality?","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib38-20230925","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"bib39-20230925","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1038\/srep13087","article-title":"Machine learning methods for quantitative radiomic biomarkers","volume":"5","year":"2015","journal-title":"Sci Rep"},{"key":"bib40-20230925","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib41-20230925","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2967\/jnumed.116.180406","article-title":"Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib42-20230925","doi-asserted-by":"crossref","first-page":"e0140830","DOI":"10.1371\/journal.pone.0140830","article-title":"Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"bib43-20230925","doi-asserted-by":"crossref","first-page":"e0210224","DOI":"10.1371\/journal.pone.0210224","article-title":"Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: a meta-analysis","volume":"14","year":"2019","journal-title":"PLoS One"},{"key":"bib44-20230925","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1088\/0031-9155\/60\/14\/5471","article-title":"A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities","volume":"60","year":"2015","journal-title":"Phys Med Biol"},{"key":"bib45-20230925","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1002\/mp.13202","article-title":"Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features","volume":"45","year":"2018","journal-title":"Med Phys"},{"key":"bib46-20230925","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2967\/jnumed.116.180919","article-title":"Reliability of PET\/CT shape and heterogeneity features in functional and morphologic components of non\u2013small cell lung cancer tumors: a repeatability analysis in a prospective multicenter cohort","volume":"58","year":"2017","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:02:07Z","timestamp":1695621727000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002732","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}